Saitama, Japan

Haruo Sekiguchi

This inventor holds 1 USPTO granted patent. Top assignee: Kyorin Seiyaku Kabushiki Kaisha. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Haruo Sekiguchi. Retrieved from https://idiyas.com/inventor/haruo-sekiguchi-33zf4ljb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruo Sekiguchi: Innovator in Therapeutic Solutions

Introduction

Haruo Sekiguchi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents for gastritis. His innovative approach has led to the creation of a unique pharmaceutical composition that addresses this common ailment.

Latest Patents

Sekiguchi holds a patent for a therapeutic agent for gastritis. This patent describes a pharmaceutical composition that contains 3,4,5-trimethoxy-N-3-piperidylbenzamide, commonly known as troxipide, as its active ingredient. The composition is designed to be administered orally in various forms, including tablets, capsules, granules, and fine granules. This versatility enhances its usability for patients suffering from gastritis.

Career Highlights

Haruo Sekiguchi is associated with Kyorin Seiyaku Kabushiki Kaisha, a company known for its commitment to developing innovative pharmaceutical solutions. His work at Kyorin has been instrumental in advancing therapeutic options for patients, particularly those dealing with gastrointestinal issues.

Collaborations

Sekiguchi has collaborated with notable colleagues, including Kazunori Kasuga and Katsuhiro Hamada. Their combined expertise has contributed to the successful development of effective therapeutic agents.

Conclusion

Haruo Sekiguchi's contributions to the pharmaceutical industry, particularly through his patent for a gastritis treatment, highlight his role as an innovator in therapeutic solutions. His work continues to impact the lives of patients seeking relief from gastrointestinal disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…